Effectiveness of Pregabalin for Treatment of Burning Mouth Syndrome
10.9758/cpn.2019.17.1.139
- Author:
Saliha Yeter AMASYALI
1
;
Aslı Akyol GÜRSES
;
Osman Nuri AYDIN
;
Ali AKYOL
Author Information
1. Department of Physical Medicine and Rehabilitation, Division of Algology, Adnan Menderes University Faculty of Medicine, Aydın, Turkey.
- Publication Type:Case Report
- Keywords:
Burning mouth syndrome;
Anticonvulsants;
Pregabalin
- MeSH:
Anticonvulsants;
Burning Mouth Syndrome;
Burns;
Consensus;
Diagnosis;
Diagnostic Tests, Routine;
Duloxetine Hydrochloride;
Humans;
Pregabalin;
Social Control, Formal
- From:Clinical Psychopharmacology and Neuroscience
2019;17(1):139-142
- CountryRepublic of Korea
- Language:English
-
Abstract:
Treatment of burning mouth syndrome (BMS) is challenging because there is no consensus regarding pharmalogical or nonpharmalogical therapies. The use of anticonvulsants is controversial. We present nine patients BMS who respond to pregabalin. They were diagnosed secondary BMS except two. Etiologic regulations were made firstly in patients with secondary BMS but symptoms did not decrease. We preferred pregabalin in all patients and got good results. Furthermore the addition of pregabalin to the treatment of two patients who did not respond adequately to duloxetine provided good results. We are only aware that pregabalin may reduce symptoms as a result of case reports. We believe that the diagnosis of pathologic etiology with appropriate diagnostic tests will result in better outcomes in treatment.
